InvestSMART

4DMedical Limited (ASX:4DX)

ALERT: Price-sensitive ASX Announcement for 4DX
Current share price for 4DX : $3.960 0.53 (15.45%)+
Announcement
Release
30 Jan 2026 10:25AM
Price at Release
$3.430
Full Release
download
Summary
4DMedical Limited has announced the expansion of its partnership with University of Chicago Medicine to include the commercial deployment of their CT:VQ™ technology. This agreement marks University of Chicago Medicine as the fifth major U.S. academic medical center to adopt CT:VQ™, joining prestigious institutions like Stanford and the Cleveland Clinic. The adoption of CT:VQ™ is seen as a validation of 4DMedical's innovative imaging solutions and commercialization strategy. The technology offers advanced functional imaging capabilities for assessing complex lung diseases and planning medical procedures, significantly enhancing clinical decision-making processes.
Key Points
  • University of Chicago Medicine expands agreement with 4DMedical to include CT:VQ™.
  • UChicago becomes the fifth U.S. academic medical center to adopt CT:VQ™.
  • The partnership includes a commercial contract and prepaid CT:VQ™ scan package.
  • CT:VQ™ is used for complex lung disease assessment and procedural planning.
  • Professor Kyle Hogarth highlights CT:VQ™'s clinical advantages at UChicago.
  • CT:VQ™ has been deployed at leading academic centers within five months of FDA clearance.
  • 4DMedical is a leader in respiratory imaging technology, utilizing advanced imaging and AI.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.